Status:
RECRUITING
Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk
Lead Sponsor:
University Hospital, Antwerp
Conditions:
Quality of Life
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Neuroendocrine tumors (NET) are rare tumors that require specific diagnosis and treatment. Therefore, this poses a challenge for clinical practice. Diagnosis and treatment can be optimized when physic...
Eligibility Criteria
Inclusion
- NEN patient
- 18 years or older
- Patient should appear in Oncobase
Exclusion
- Patients who do not have an email address
Key Trial Info
Start Date :
November 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05268783
Start Date
November 5 2018
End Date
December 31 2029
Last Update
March 24 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Klina
Brasschaat, Antwerp, Belgium, 2930
2
AZ Monica
Deurne, Antwerp, Belgium, 2100
3
Antwerp University Hospital
Edegem, Antwerp, Belgium, 2650
4
AZ Rivierenland
Rumst, Antwerp, Belgium, 2840